U.S. Navy seeks FDA approval for clinical trial of Hemopure

12/11/2008 | MedGadget.com

The U.S. Naval Medical Research Center has submitted to the FDA a revised application to commence a clinical trial of Hemopure -- a stabilized hemoglobin used in the treatment of trauma patients in the battlefield. Hemopure, a product of Mass.-based firm Biopure, would eliminate the need for blood transfusions after surgery by helping patients build up their own reserves of red blood cells.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA